Author
Listed:
- Xuan Li
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
- Xiao-Qi Wu
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University
The 3rd Affiliated Hospital, Sun Yat-sen University)
- Rong Deng
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
- Dan-Dan Li
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
- Jun Tang
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
- Wen-Dan Chen
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
- Jing-Hong Chen
(The Second Affiliated Hospital, Guangzhou Medical University)
- Jiao Ji
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
- Lin Jiao
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
- Shan Jiang
(The First Affiliated Hospital, Chongqing Medical University)
- Fen Yang
(Nanjing Medical University)
- Gong-Kan Feng
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
- Ravichandran Senthilkumar
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
- Fei Yue
(Texas A&M University Health Science Center)
- Hai-Liang Zhang
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
- Rui-Yan Wu
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
- Yan Yu
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
- Xue-Lian Xu
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
- Jia Mai
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
- Zhi-Ling Li
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
- Xiao-Dan Peng
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
- Yun Huang
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
- Xiang Huang
(Jinan University)
- Ning-Fang Ma
(School of Basic Medical Sciences, Affiliated Cancer Hospital and Institute of Guangzhou Medical University)
- Qian Tao
(Prince of Wales Hospital, The Chinese University of Hong Kong)
- Yi-Xin Zeng
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
- Xiao-Feng Zhu
(Collaborative Innovation Center for Cancer Medicine, Cancer Center, Sun Yat-sen University)
Abstract
Autophagy is a degradative pathway that delivers cellular components to the lysosome for degradation. The role of autophagy in cell differentiation is poorly understood. Here we show that CaMKII can directly phosphorylate Beclin 1 at Ser90 to promote K63-linked ubiquitination of Beclin 1 and activation of autophagy. Meanwhile, CaMKII can also promote K63-linked ubiquitination of inhibitor of differentiation 1/2 (Id-1/2) by catalyzing phosphorylation of Id proteins and recruiting TRAF-6. Ubiquitinated Id-1/Id-2 can then bind to p62 and be transported to autolysosomes for degradation. Id degradation promotes the differentiation of neuroblastoma cells and reduces the proportion of stem-like cells. Our study proposes a mechanism by which autophagic degradation of Id proteins can regulate cell differentiation. This suggests that targeting of CaMKII and the regulation of autophagic degradation of Id may be an effective therapeutic strategy to induce cell differentiation in neuroblastoma.
Suggested Citation
Xuan Li & Xiao-Qi Wu & Rong Deng & Dan-Dan Li & Jun Tang & Wen-Dan Chen & Jing-Hong Chen & Jiao Ji & Lin Jiao & Shan Jiang & Fen Yang & Gong-Kan Feng & Ravichandran Senthilkumar & Fei Yue & Hai-Liang , 2017.
"CaMKII-mediated Beclin 1 phosphorylation regulates autophagy that promotes degradation of Id and neuroblastoma cell differentiation,"
Nature Communications, Nature, vol. 8(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-01272-2
DOI: 10.1038/s41467-017-01272-2
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Shiyan Liu & Mutian Chen & Yichang Wang & Yuqing Lei & Ting Huang & Yabin Zhang & Sin Man Lam & Huihui Li & Shiqian Qi & Jia Geng & Kefeng Lu, 2023.
"The ER calcium channel Csg2 integrates sphingolipid metabolism with autophagy,"
Nature Communications, Nature, vol. 14(1), pages 1-19, December.
- Shuang Shang & Chen Yang & Fei Chen & Ren-shen Xiang & Huan Zhang & Shu-yuan Dai & Jing Liu & Xiao-xi Lv & Cheng Zhang & Xiao-tong Liu & Qi Zhang & Shuai-bing Lu & Jia-wei Song & Jiao-jiao Yu & Ji-cha, 2023.
"ID1 expressing macrophages support cancer cell stemness and limit CD8+ T cell infiltration in colorectal cancer,"
Nature Communications, Nature, vol. 14(1), pages 1-19, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-01272-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.